Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT05768503	TitleComparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC	Fase Fase 3	Date Added 2023-03-14	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Control Rx, Experimental drug	Etiquetas MSS/ MMRp
NCT ID NCT05759728	TitleEstudio de CNA3103 (células CAR-T autólogas dirigidas a LGR5) administrado a sujetos con cáncer colorrectal metastásico.	Fase Fase 1	Date Added 2023-03-08	Ubicación Australia	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05743036	TitleZN-c3 in Adult Participants With BRAF mutant Metastatic Colorectal Cancer	Fase Fase 1	Date Added 2023-02-24	Ubicación California, United States Kansas, United States Texas, United States Australia Alemania Hungary Italia Polonia España	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas cetuximab, encorafenib, ZN-c3	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05733611	TitleRP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC	Fase Fase 2	Date Added 2023-02-17	Ubicación	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas	Etiquetas MSS/ MMRp
NCT ID NCT05726864	TitleA Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors	Fase Phase 1, Phase 2	Date Added 2023-02-14	Ubicación Arizona, United States California, United States Colorado, United States Florida, United States Georgia, United States Iowa, United States Louisiana, United States Massachusetts, United States Michigan, United States Minnesota, United States New York, United States Pennsylvania, United States Tennessee, United States Texas, United States Wisconsin, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas ELI-002 7P	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05722327	TitlePhase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer	Fase Fase 1	Date Added 2023-02-10	Ubicación Texas, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas cetuximab, Irinotecan, MRTX849	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05714553	TitleNUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours	Fase Phase 1, Phase 2	Date Added 2023-02-06	Ubicación Reino Unido	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Docetaxel, Fosifloxuridine Nafalbenamide, Leucovorin, Pembrolizumab	Etiquetas MSI-H/ MMRd
NCT ID NCT05684211	TitleUn estudio de ametumumab en combinación con un anticuerpo monoclonal anti-PD-1 y FOLFIRI en pacientes con cáncer colorrectal avanzado de tipo RAS salvaje	Fase Fase 2	Date Added 2023-01-13	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Aún no se ha contratado	Drogas Ametumumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05677113	TitleA Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver	Fase Fase 2	Date Added 2023-01-10	Ubicación Canadá	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Placebo, QBECO	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05676190	TitleClinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer	Fase No aplicable	Date Added 2023-01-09	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 71 to 80 of 299 entries